Glenmede Trust’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.6M | Sell |
95,969
-35,418
| -27% | -$1.52M | 0.02% | 465 |
|
|
2026
Q1 | $4.83M | Sell |
131,387
-29,374
| -18% | -$1.39M | 0.02% | 447 |
|
|
2025
Q4 | $8.18M | Buy |
+160,761
| New | +$8.22M | 0.04% | 380 |
|
|
2025
Q1 | $11.5M | Sell |
165,835
-131,757
| -44% | -$10.9M | 0.06% | 328 |
|
|
2024
Q4 | $25.6M | Buy |
297,592
+2,162
| +0.7% | +$234K | 0.13% | 145 |
|
|
2024
Q3 | $35.2M | Sell |
295,430
-5,143
| -2% | -$686K | 0.17% | 117 |
|
|
2024
Q2 | $42.9M | Buy |
300,573
+14,253
| +5% | +$1.89M | 0.22% | 96 |
|
|
2024
Q1 | $36.8M | Buy |
286,320
+28,256
| +11% | +$3.36M | 0.18% | 117 |
|
|
2023
Q4 | $26.7M | Buy |
258,064
+665
| +0.3% | +$65.8K | 0.14% | 155 |
|
|
2023
Q3 | $23.4M | Buy |
257,399
+47,005
| +22% | +$4.14M | 0.13% | 164 |
|
|
2023
Q2 | $16.7M | Hold |
210,394
| – | – | 0.1% | 229 |
|
|
2023
Q1 | $16.7M | Sell |
210,394
-3,178
| -1% | -$225K | 0.1% | 228 |
|
|
2022
Q4 | $14.5M | Sell |
213,572
-2,556
| -1% | -$150K | 0.08% | 264 |
|
|
2022
Q3 | $10.8M | Sell |
216,128
-5,428
| -2% | -$291K | 0.07% | 303 |
|
|
2022
Q2 | $12.3M | Sell |
221,556
-60,616
| -21% | -$3.36M | 0.07% | 309 |
|
|
2022
Q1 | $15.7M | Buy |
282,172
+22,068
| +8% | +$1.13M | 0.08% | 304 |
|
|
2021
Q4 | $14.6M | Sell |
260,104
-7,962
| -3% | -$431K | 0.07% | 323 |
|
|
2021
Q3 | $12.9M | Sell |
268,066
-40,640
| -13% | -$1.96M | 0.07% | 319 |
|
|
2021
Q2 | $12.9M | Sell |
308,706
-10,102
| -3% | -$392K | 0.07% | 314 |
|
|
2021
Q1 | $10.7M | Sell |
318,808
-32,410
| -9% | -$1.15M | 0.06% | 319 |
|
|
2020
Q4 | $12.3M | Buy |
351,218
+4,208
| +1% | +$145K | 0.07% | 299 |
|
|
2020
Q3 | $12M | Sell |
347,010
-2,086
| -0.6% | -$69.5K | 0.07% | 287 |
|
|
2020
Q2 | $11.4M | Sell |
349,096
-16,252
| -4% | -$519K | 0.07% | 289 |
|
|
2020
Q1 | $10.6M | Hold |
365,348
| – | – | 0.05% | 361 |
|
|
2019
Q4 | $10.6M | Buy |
365,348
+1,212
| +0.3% | +$33.6K | 0.05% | 361 |
|
|
2019
Q3 | $9.41M | Buy |
364,136
+4,134
| +1% | +$105K | 0.04% | 360 |
|
|
2019
Q2 | $9.19M | Buy |
360,002
+1,906
| +0.5% | +$47.1K | 0.04% | 383 |
|
|
2019
Q1 | $9.36M | Buy |
358,096
+112
| +0% | +$2.75K | 0.04% | 382 |
|
|
2018
Q4 | $8.24M | Sell |
357,984
-153,316
| -30% | -$3.41M | 0.04% | 366 |
|
|
2018
Q3 | $12.1M | Buy |
511,300
+148,774
| +41% | +$3.63M | 0.05% | 362 |
|
|
2018
Q2 | $8.36M | Sell |
362,526
-210,814
| -37% | -$5.01M | 0.04% | 385 |
|
|
2018
Q1 | $15.4M | Hold |
573,340
| – | – | 0.06% | 332 |
|
|
2017
Q4 | $15.4M | Sell |
573,340
-179,248
| -24% | -$4.56M | 0.06% | 332 |
|
|
2017
Q3 | $18.1M | Sell |
752,588
-15,206
| -2% | -$344K | 0.08% | 307 |
|
|
2017
Q2 | $13.2M | Hold |
767,794
| – | – | 0.06% | 338 |
|
|
2017
Q1 | $13.2M | Buy |
767,794
+201,740
| +36% | +$3.51M | 0.06% | 338 |
|
|
2016
Q4 | $10.1M | Sell |
566,054
-48,810
| -8% | -$885K | 0.06% | 359 |
|
|
2016
Q3 | $12.8M | Sell |
614,864
-94,702
| -13% | -$2.35M | 0.07% | 341 |
|
|
2016
Q2 | $19.1M | Sell |
709,566
-5,162
| -0.7% | -$142K | 0.12% | 277 |
|
|
2016
Q1 | $19.4M | Sell |
714,728
-149,782
| -17% | -$4.01M | 0.13% | 264 |
|
|
2015
Q4 | $25.1M | Buy |
864,510
+62,616
| +8% | +$1.73M | 0.17% | 191 |
|
|
2015
Q3 | $21.7M | Buy |
801,894
+45,182
| +6% | +$1.28M | 0.16% | 216 |
|
|
2015
Q2 | $20.7M | Sell |
756,712
-15,226
| -2% | -$428K | 0.15% | 229 |
|
|
2015
Q1 | $20.6M | Buy |
771,938
+128,982
| +20% | +$2.97M | 0.15% | 225 |
|
|
2014
Q4 | $13.6M | Sell |
642,956
-19,982
| -3% | -$446K | 0.11% | 289 |
|
|
2014
Q3 | $15.8M | Sell |
662,938
-39,952
| -6% | -$919K | 0.14% | 231 |
|
|
2014
Q2 | $16.2M | Sell |
702,890
-34,370
| -5% | -$759K | 0.15% | 215 |
|
|
2014
Q1 | $16.8M | Buy |
737,260
+8,050
| +1% | +$172K | 0.16% | 176 |
|
|
2013
Q4 | $13.5M | Sell |
729,210
-18,080
| -2% | -$315K | 0.14% | 199 |
|
|
2013
Q3 | $12.6M | Sell |
747,290
-28,890
| -4% | -$486K | 0.15% | 167 |
|
|
2013
Q2 | $12M | Buy |
+776,180
| New | +$12.9M | 0.15% | 142 |
|
Other funds holding NVO
F
Glenmede Trust's NVO Position: Q2 2026 in Review
Glenmede Trust reduced its Novo Nordisk (NVO) stake by 27% in Q2 2026, selling an estimated $1.52M and leaving 95,969 shares worth $4.6M. The position accounts for 0.02% of the portfolio, ranked #465.
Glenmede Trust first reported a position in NVO in Q2 2013 and has held it in 51 quarters since. The position peaked at $42.9M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Glenmede Trust held 95,969 shares of Novo Nordisk worth $4.6M as of Q2 2026.
- Glenmede Trust sold 35,418 Novo Nordisk shares in Q2 2026, an estimated $1.52M.
- Novo Nordisk made up 0.02% of Glenmede Trust's portfolio in Q2 2026, its #465 holding.
- Glenmede Trust first reported a position in Novo Nordisk in Q2 2013 and has held it in 51 quarters since.
- Glenmede Trust's Novo Nordisk position peaked at $42.9M in Q2 2024.
- 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.